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Abstract
A major focus of research in alcohol-related disorders is to identify the genes and pathways that 
modulate alcohol-seeking behavior. In light of this, animal models have been established to study 
various aspects of alcohol dependence. The selectively bred alcohol-preferring (P) and -
nonpreferring (NP) lines were developed from Wistar rats to model high and low voluntary 
alcohol consumption, respectively. Using inbred P and NP strains, a strong QTL (LOD-9.2) for 
alcohol consumption was identified on rat chromosome 4. To search for candidate genes that 
underlie this chromosomal region, complementary molecular-based strategies were implemented 
to identify genetic targets that likely contribute to the linkage signal. In an attempt to validate 
these genetic targets, corroborative studies have been utilized including pharmacological studies, 
knock-out/transgenic models as well as human association studies. Thus far, three candidate 
genes, neuropeptide Y (Npy), α-synuclein (Snca), and corticotrophin-releasing factor receptor 2 
(Crhr2), have been identified that may account for the linkage signal. With the recent 
advancements in bioinformatics and molecular biology, QTL analysis combined with molecular-
based strategies provides a systematic approach to identify candidate genes that contribute to 
various aspects of addictive behavior.
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INTRODUCTION
The identification of genes that influence alcohol dependence represents an important facet 
of drug abuse research. These genes can provide insight into the neurobiological and 
metabolic components that influence addictive behaviors. In addition, genetic factors can be 
targeted for pharmaceutical development and can likely be used to screen predisposed 
individuals and to better diagnose comorbid psychiatric disorders. For almost two decades, 
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quantitative trait locus (QTL) analysis has been applied to various rodent models resulting in 
only limited success [1]. This article will review the research strategies that have been 
applied to the selectively bred alcohol-preferring (P) and –nonpreferring (NP) model in 
order to target and attempt to validate candidate genes from a QTL for alcohol consumption 
[2].
Alcoholism is a complex psychiatric disorder influenced by both genes and the environment. 
Selective breeding has been implemented to study the various aspects of alcohol dependence 
[3]. By applying selective breeding, one can increase the frequency of trait-relevant alleles 
that are associated with a specific phenotype (e.g. alcohol consumption) in a population 
resulting in consistent and reliable phenotypic differences. Likewise, the P and NP lines 
were selectively bred from Wistar rats for high and low alcohol consumption, respectively 
[4]. In this model, P rats exhibit several features that are consistent with alcoholism in 
humans [5]. For example, P rats (1) orally self-administer ethanol in pharmacologically 
relevant amounts; (2) consume EtOH for its pharmacological effects (not caloric value or 
taste); (3) show positive reinforcement; (4) develop tolerance; and (5) exhibit withdrawal 
symptoms [6, 7]. To date, a plethora of correlative studies have been conducted to study the 
behavioral and neurobiological differences between the P and NP lines [7]. However, these 
studies have only provided limited information about the primary genetic factors that 
underlie these phenotypic differences. Therefore, the primary purpose of the candidate gene 
approach is to identify the genes that either cause or contribute to a disease or related 
phenotype (e.g., alcohol dependence).
To conduct genetic studies, inbred P (iP) and inbred NP (iNP) strains were developed from 
the selectively bred P and NP lines by performing brother-sister mating for over 20 
generations [8]. The resulting iP and iNP strains maintain highly discordant alcohol 
consumption scores [2]. These inbred animals are virtually genetically homogeneous, and 
phenotypic differences within the inbred strain can largely be attributed to environmental 
factors. By decreasing the genomic variability within a population, inbreeding improves the 
likelihood of identifying the genetic factor(s) that are associated with a heritable trait like 
alcohol consumption.
Several complementary approaches have been applied to the iP and iNP strains to identify 
candidate genes that contribute to the differences in alcohol-seeking behavior (Fig. 1). First, 
chromosomal regions (QTLs) associated with alcohol consumption in the iP and iNP strains 
were mapped through linkage analysis and then bred into congenic strains using marker-
assisted breeding strategies. Second, complementary molecular techniques [i.e. sequence 
analysis, gene expression (mRNA, protein)] were implemented to screen and prioritize 
“target” genes that may underlie the observed QTL. Third, independent studies including 
genetic (knockout, transgenic) [9, 10], pharmacological [11–13], and human studies of 
association [14–17] have provided corroborative evidence that has been used in an attempt 
to validate individual “candidate” genes of interest identified in the P and NP model.
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QUANTITATIVE TRAIT LOCUS (QTL) MAPPING
Mapping a QTL often represents the first step in a long process with the ultimate goal of 
identifying the gene(s) underlying a QTL of interest. QTL analysis was developed to 
identify chromosomal regions that are associated with a quantitative phenotype [18]. Unlike 
knockout and transgenic strategies, QTL analysis detects natural variability captured either 
by selective breeding or inbreeding. Derived from two parent populations, F1 animals are 
genetically identical and heterozygous at every locus throughout the genome. In the F2 
population, a random distribution of genetic variability inherent in the parent strains is 
generated as a result of chromosomal recombination. Therefore, a QTL indicates that a 
significant correlation exists between polymorphic markers and a phenotypic measure 
determined for the F2 population. Applied to an iP x iNP F2 population, linkage analysis 
detected a highly significant QTL [logarithm of the odds (LOD) score = 9.2] for alcohol 
consumption on rat chromosome 4 (Fig. 2); [2, 19]. Due to the strong association, this 
chromosomal region likely harbors genes that influence alcohol consumption in the iP and 
iNP strains.
QTL regions are often broad [e.g., 20 centiMorgans (cM)] and can contain hundreds of 
genes. The generation of congenic strains represents an extension of QTL analysis that is 
commonly employed to confirm and fine-map a QTL region. This strategy involves 
transferring a QTL interval from one inbred strain (i.e. donor strain) into another inbred 
strain (i.e. recipient strain) using marker-assisted breeding over ten generations of 
backcrossing [20]. With each generation, the chromosomal interval (QTL) of the donor 
strain is preserved, while approximately one half of the donor genome is replaced by the 
genome of the recipient strain. After ten generations, heterozygotes for the donor region are 
intercrossed to generate congenic strains. The resulting congenic strains are homozygous at 
the QTL locus, but contain 99.9% of the genome from the recipient strain.
Following QTL analysis, reciprocal congenic strains were developed by transferring the 
chromosome 4 QTL into the respective iP or iNP backgrounds [21]. Using genomic DNA, 
four microsatellite markers (D4Mgh16, D4Rat30, D4Arb21, and D4Rat55) were genotyped 
to determine the donors for each subsequent generation. Following ten generations of 
backcrossing, the resulting animals were intercrossed to produce two homozygous congenic 
strains termed P.NP and NP.P. The P.NP strain contains the iNP chromosome 4 QTL region 
introgressed into the iP background, while the NP.P strain contains the iP chromosome 4 
QTL region introgressed into the iNP background. Compared to their respective iP and iNP 
background strains, the P.NP and NP.P congenic strains exhibit the expected phenotypic 
differences in alcohol consumption that are consistent with a successful capture of the 
chromosome 4 QTL [21]. The P.NP strain displayed a significant decrease in alcohol 
consumption relative to the iP strain (p=0.001), while the NP.P strain exhibited a significant 
increase in alcohol consumption relative to the iNP strain (p=0.0005) [21]. However, the 
introgressed region in the P.NP and NP.P congenic strains is approximately 20–25 cM and 
still contains hundreds of genes.
Following the development of congenic strains, marker-assisted breeding can subsequently 
be applied to generate interval specific congenic strains (ISCSs). This breeding strategy 
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identifies and then exploits chromosomal recombination within the QTL region. To develop 
ISCSs, the congenic strain (e.g., NP.P) is again bred with its background strain (e.g., iNP) to 
generate heterozygous animals. These heterozygous animals are again crossed with the 
background strain, ultimately producing some animals that encode smaller segments of the 
QTL region than the original congenic strain. These animals are subsequently bred to create 
stable ISCSs that can be tested to determine whether the QTL of interest is conserved. To 
date, this strategy has been successfully applied in various genetic studies of alcohol-related 
behaviors [22–24].
As an extension of QTL analysis, the development of ISCSs provides important advantages 
for candidate gene identification. First, marker-assisted breeding clearly defines and can 
reduce the chromosomal region associated with the QTL. By reducing the size of the QTL 
interval, fine-mapping through the development of ISCSs limits the number of possible 
genes that underlie the QTL interval. Thereby, fine-mapping improves the likelihood of 
candidate gene identification. In addition, a linkage signal can potentially result from a 
cumulative effect of multiple loci. These loci can independently contribute to the phenotypic 
variance associated with QTL region [25, 26]. The generation of ISCSs can be used to 
dissect the QTL region in order to segregate the effects of these specific loci. In the P and 
NP model, the development and testing of ISCSs is nearing completion and is expected to 
reduce the chromosome 4 QTL interval to roughly 1–2 cM. Ultimately, fine-mapping 
through the development of ISCSs represents the final step in QTL mapping and can be 
utilized to help delineate the effect(s) (e.g., biochemical, neurobiological, behavioral) of the 
gene(s) associated with a linkage signal.
CANDIDATE GENE PRIORITIZATION
QTL mapping has been widely used to identify chromosomal regions that are associated 
with a quantitative trait like alcohol consumption. However, the strategies to localize 
candidate genes underlying a QTL are still being developed. The task of identifying specific 
genes that contribute to a linkage signal is difficult because QTLs can often encompass 
broad chromosomal regions with hundreds of possible candidate genes. For example, the 
95% confidence interval of the QTL identified on rat chromosome 4 spans 12.5 cM, and a 
significant LOD score (above 4) is detected for roughly 25 cM [19]. To screen for likely 
genetic targets, complementary molecular-based techniques were applied to iP and iNP 
strains to target specific genes that may contribute to the linkage signal identified on rat 
chromosome 4.
Bioinformatics & Literature
Until recently, the specific location of a gene in the genome was often poorly localized. For 
instance, the exact location of alpha-synuclein (Snca) in the rat was unknown until it was 
mapped using recombination-based methods in the iP and iNP strains [27]. Due to the 
advancement in bioinformatics and mapping techniques, the location of almost every gene 
throughout the genome can now be determined. While often broad, a QTL region defines a 
finite chromosomal interval with a limited number of genes. With current bioinformatics 
tools, all possible genes underlying a QTL region can now be identified. Combined with 
other bioinformatics resources, each of these genes can theoretically be screened and 
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prioritized for their potential relevance to the quantitative trait of interest, thus, providing 
targets for molecular-based research [28]. Therefore, the literature and bioinformactics 
affords an additional, complementary tool that can help demarcate a specific gene of interest 
from a broad QTL region with a multitude of differentially expressed genes [29].
Several online databases were employed to map the genes that reside in the chromosome 4 
QTL region. These databases include Ensembl Genome Browser (www.ensembl.org), Rat 
Genome database (www.rgd.mcw.edu), and Ratmap (www.ratmap.gen.gu.se). Following 
gene mapping, search engines like Pubmed (www.ncbi.nlm.nih.gov) were utilized to sort 
and prioritize genes based on their known biology as well as their relevance to alcohol-
related phenotypes (e.g. biochemical, physiological, comorbidity, etc.). Ultimately, 
neuropeptide Y (Npy), Snca and corticotrophin-releasing factor repector 2 (Crhr2) were 
prioritized for further characterization using molecular-based research because they: (1) 
exhibit a close proximity to the peak of the linkage signal; (2) show biological correlates that 
are relevant to alcohol dependence or an alcohol-related phenotype; and (3) display 
differences in gene expression (RNA, protein) between the P and NP strains.
Molecular-Based Research
Molecular-based strategies can be effectively used to screen and target genes that contribute 
to a QTL. A QTL represents the effect(s) of a specific biologically active variant(s) on a 
phenotypic measure. These allelic variants likely include the following: (1) coding 
polymorphisms that alter protein structure or enzyme function; (2) regulatory 
polymorphisms that affect gene expression (RNA, protein) or mRNA stability; (3) structural 
genomic variation (copy number variants); (4) DNA methylation polymorphisms; and (5) 
mitochondrial polymorphisms. Thus, the underlying biological mechanisms that drive a 
QTL are distinctly molecular in nature. Molecular-based techniques provide a means to 
detect relevant genetic artifacts and to characterize their effects on gene expression and 
function.
Applied to the P and NP model, QTL analysis and molecular-based research were utilized as 
complementary strategies to filter and target specific genes of interest to alcohol-seeking 
behavior. Gene expression studies were utilized as a functional measure to characterize the 
effects of regulatory polymorphisms on gene expression (mRNA, protein). In addition, 
sequence analysis was used to screen differentially expressed genes for underlying genetic 
polymorphism (coding, regulatory). These studies were followed by in vitro methods (i.e. 
luciferase) to assess the functional significance of individual polymorphisms. By inserting 
specific DNA sequence variants into a luciferase (luc) reporter vector, their effects on 
luciferase gene expression can be determined. Luciferase reporter gene assays can provide 
valuable insight into the regulatory polymorphism that may underlie differences in gene 
expression, establishing whether a polymorphism is functional in cell lines (e.g., 
neuroblastoma) that express the gene of interest.
Screening a QTL region for genes that display differences in mRNA expression provides an 
important strategy that has been utilized to target “potential” candidate genes [29–32]. 
However, gene expression profiling studies have several limitations that can make the 
results difficult to interpret [31]. First, the specificity of tissue dissection can significantly 
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influence the resolution of gene expression studies, and gene expression is often not 
uniformly distributed or static, but can exhibit differences in spatial and temporal regulation. 
Second, inherent limitations in sensitivity can hamper the detection of differentially 
expressed genes that exhibit lower levels of expression (i.e. receptors). Third, RNA 
expression data from gene expression profiling can also be influenced by the data analysis 
and filtering methods. Finally, small sample sizes can also limit the resolution and power of 
gene expression studies.
Comparing the iP and iNP strains using analytic tools available from the Bioconductor 
Project [33], mRNA expression was measured using several techniques including real-time 
quantitative reverse transcription PCR (qRT-PCR), total gene expression analysis (TOGA) 
[34], and microarray analysis. These expression studies primarily targeted brain tissues 
associated with the mesocorticolimbic dopamine (DA) system and included the frontal 
cortex, hippocampus, hypothalamus, caudate-putamen, amygdala, and nucleus accumbens 
[27, 28, 35]. These brain regions were primarily selected due to their involvement in the 
mesocorticolimbic DA system, a system that modulates the rewarding properties of drugs of 
abuse and functions through reciprocal interactions between the ventral tegmental area 
(VTA) and various limbic structures [6].
Three candidate genes (Npy, Snca, Crhr2) were initially screened and selected based on their 
proximity to the peak of the QTL and their gene expression profile. For the three candidate 
genes, three independent mRNA expression studies resulted in some inconsistent findings. 
For example, significant differences in Npy mRNA expression were detected between the iP 
and iNP strains in mesolimbic regions using microarray analysis and qRT-PCR [35, 36], but 
were not detected using TOGA [27]. For Snca, TOGA and qRT-PCR detected differences in 
mRNA expression when comparing the iP and iNP strains [27]; however, these differences 
were not seen using microarray analysis [35]. Finally, qRT-PCR detected differences in 
Crhr2 mRNA expression [37], but these differences were not detected between the iP and 
iNP strains using microarray analysis or TOGA [27, 35].
These inconsistencies suggest that additional independent molecular-based measures (RNA, 
protein) are essential to limit both false positives and false negatives that can result from 
gene expression profiling. For example, both NPY and SNCA protein levels exhibited 
significant differences between the iP and iNP strains providing evidence that these genes 
are differentially expressed between the P and NP strains and may be functionally 
significant [27, 38]. In addition, the inconsistencies seen in Crhr2 mRNA expression (qRT-
PCR, microarray, TOGA) may have resulted from a low level of Crhr2 mRNA expression 
detected by qRT-PCR in both the iP and iNP strains, suggesting that limitations in 
sensitivity may be an important factor to consider [37].
To target candidate genes, congenic strains potentially provide an advantage over inbred 
strains for gene expression studies. Gene regulation can be influenced by both cis-acting 
elements as well as transcription factors (trans-acting factors). Cis-acting elements are 
present on the same strand and chromosome as the gene they regulate and are binding sites 
for transcription factors that regulate gene transcription. A cis-element may be located in the 
promoter region 5′ to the gene it controls, in an intron, or in the 3′ untranslated region 
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(3′UTR). Unlike cis-acting elements, transcription factors regulate genes distant from the 
gene from which they were transcribed.
In congenic strains, regulatory polymorphism in cis-acting elements (within the gene/QTL) 
is preserved, while the genetic variation outside the gene/QTL is significantly decreased 
because the background and congenic strains are virtually identical outside the QTL region. 
As a result, genes differentially expressed in the congenic animals outside the QTL region 
compared to the background strain are likely due to a regulatory gene located within the 
chromosome 4 region, and the development of congenic strains should theoretically 
decrease the effects of polymorphism that reside outside the region (trans-acting effects) on 
gene expression within the QTL. Therefore, the congenic gene expression profile (NP.P) 
within the QTL should be more consistent with that of the progenitor (iP), while the 
expression profile of genes outside the QTL region should be more minimized and more 
consistent with that of the background strain (iNP).
Comparing the NP.P congenic strain to the iNP background strain, microarray analysis 
detected mRNA expression differences in 13 known genes that reside in the QTL interval 
[28]. In addition, various genes in the PKC signal transduction pathway were identified [28]. 
Both Npy and Snca mRNA displayed significant differences in expression when the data 
from all five discrete brain regions from each animal were averaged. However, Npy mRNA 
expression differences were not confirmed using qRT-PCR. For Snca, mRNA expression 
was increased in the iNP relative to the NP.P strain indicating that the transfer of the QTL 
region did not significantly affect the direction of Snca mRNA expression. These results 
suggest that Snca mRNA expression is more prominently regulated by trans- than cis-
regulating factors. A difference in Crhr2 mRNA expression was not detected by microarray 
analysis.
Protein content has not yet been measured in the NP.P congenic strain to confirm these 
mRNA expression results. While gene expression profiling when applied to inbred and 
congenic strains represents an important tool in the search for the gene(s) and biochemical 
pathway(s) that contributes to a linkage signal, inherent limitations predicate the use of 
independent molecular-based measures (mRNA, protein) for gene confirmation and 
prioritization. Gene expression profiling is on-going using the newly developed P.NP strain 
and will likely provide further insight.
Correlative Studies Using Congenic Strains
While many correlative studies (behavioral, neurobiological) have been conducted to study 
the differences between the P and NP lines [7], these genotypic correlations have not yet 
been examined in the newly developed P.NP and NP.P congenic strains. Hypothesis-driven 
research can be utilized to extend these correlative findings to congenic strains. For 
example, these correlative studies can yield important information regarding how the 
transfer of the QTL affects phenotypic measures (biochemical, neurobiological, behavioral) 
associated with quantitative trait as well as a specific genetic target(s). Furthermore, strong 
correlations established between selectively bred or inbred strains can be studied in congenic 
strains in order to provide evidence that these genotypic correlations are likely to be trait-
relevant. In short, phenotypes that are inherited with a QTL and are consistent with the 
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known biology of a genetic target can significantly strengthen the case for the nomination of 
an individual candidate gene.
The P.NP and NP.P congenic strains were primarily developed to confirm and narrow the 
chromosome 4 QTL interval, thereby, limiting the number of possible candidate genes. 
However, the P.NP and NP.P congenic strains were also utilized to study the effect of the 
transfer of the chromosome 4 QTL on other phenotypes. In addition to alcohol consumption 
[21], the transfer of the chromosome 4 QTL significantly affects body weight and bone 
phenotypes. For example, the congenic NP.P strain weighs significantly less than the iNP 
strain, and the P.NP strain weighs significantly more than the iP strain [39]. Using the iP x 
iNP F2 population [2], a QTL for body weight (LOD-5.4) was mapped to rat chromosome 4 
in males. Likewise, bone phenotypes were measured in the congenic and inbred strains. 
Relative to the iP strain, the congenic P.NP strain exhibit decreased bone mass and strength 
[40]. These phenotypic correlates (i.e., body weight, bone) are consistent with the expected 
differences in Npy expression (mRNA, protein). Thus, these results may be indicative of a 
pleiotropic effect(s) associated with Npy or the effects of distinct biologically active variants 
that were co-selected due to genetic linkage.
CORROBORATIVE EVIDENCE AND CANDIDATE GENE VALIDATION
While no formal criteria have yet been established, a “candidate gene” is principally defined 
by the body of evidence supporting a gene’s candidacy. The identification of promising 
genetic targets (i.e. Npy, Snca, Crhr2) that map to a QTL and show strain-specific molecular 
and phenotypic correlations can provide a starting point for hypothesis-driven research. 
Hypothesis-driven research can ultimately yield important corroborative evidence that can 
be used in an attempt to further validate each candidate gene of interest. For example, 
transgenic and knockout strains can be used to determine how the direct genetic 
manipulation of gene expression affects alcohol-related phenotypes. In addition, 
pharmacological and human association studies can be conducted to further characterize the 
relationship between the genetic factor and the alcohol-related phenotypes. Applied to the 
three candidate genes that are most likely to contribute to the chromosome 4 QTL, these 
approaches represented independent, corroborative measures that better define the relevance 
of each candidate gene (Npy, Snca, Crhr2) to alcohol dependence.
Neuropeptide Y (Npy)
NPY is considered an important neuromodulator in the central nervous system, particularly 
in the amygdala and the hypothalamus. To date, studies have implicated Npy in the 
regulation of emotion, anxiety, consummatory behavior as well as alcohol dependence [41]. 
An inverse relationship has been documented between Npy levels (mRNA, protein) and 
alcohol-seeking behavior. For example, lower levels of Npy mRNA and protein were 
detected in P relative to NP rats in various regions in the mesolimbic system including the 
hypothalamus and amygdala [36, 38, 42]. Several variants in Npy’s DNA sequence were 
detected between the iP and iNP strains [36]. Using neuroblastoma cells, in vitro expression 
studies yielded a significant decrease in luciferase expression of the iP-(2nd intron)-luc 
construct relative to the NP-(2nd intron)-luc construct (p<0.05) suggesting that Npy 
expression may be regulated at the transcriptional level [36]. In addition, 
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intracerebroventricular infusion of NPY has been shown to reduce ethanol intake in the P rat 
[11]. Mice deficient in NPY exhibit increased alcohol consumption compared to wild-type 
mice, and an over-expression of NPY decreases ethanol consumption in transgenic mice [9]. 
In humans, a polymorphism in Npy (Leu7Pro) was significantly associated with alcohol 
dependence in human alcoholics [14, 15].
It has been well-documented that the P and NP strains exhibit marked differences in anxiety-
like behavior with studies suggesting that P rats are more “anxious” than NP rats. Compared 
with NP rats, P rats: (1) showed greater foot-shock-induced suppression of operant 
responding in an approach-avoidance conflict test; (2) spent less time in the open arms of an 
elevated plus maze; and (3) took longer in a passive avoidance test to step down from a 
platform to a grid floor where footshock was received 24 hours earlier [43]. In addition, both 
acoustic startle and potentiated startle response were consistently greater in P than NP rats, 
and only P rats showed significant fear-conditioned startle [44]. Therefore, due to NPY’s 
role in the modulation of behavioral effects of stress, particularly anxiety-like behavior ([45] 
see following reviews [46; 47]), Npy may represent an important biologic target for alcohol-
seeking behavior, especially in the P and NP model.
Alpha-Synuclein (Snca)
Snca has primarily been implicated in neurodegenerative disorders, especially in Parkinson’s 
disease [48]. Studies suggest that SNCA plays an important role in the regulation of 
dopaminergic neurotransmission including dopamine synthesis, storage, release and re-
uptake [49–54]. For Snca, a direct relationship has been established between Snca 
expression (mRNA, protein) and alcohol-seeking behavior. For example, the iP rats exhibit 
higher Snca mRNA & protein levels in the hippocampus relative to iNP rats [27]. 
Comparing the Snca DNA sequence of the iP and iNP strains, five variants were detected in 
the Snca promoter region and two in the 3′-untranslated region (3′UTR) [27, 55]. While the 
promoter polymorphisms did not affect luciferase gene expression, the 3′UTR (+679) 
polymorphism appears to be functional and luciferase expression levels are consistent with 
the mRNA and protein findings [27]. Subsequently, a study found that the iP polymorphism 
(+679) is also associated with a significantly longer mRNA half-life suggesting that mRNA 
stability may contribute to the differences seen in Snca expression (mRNA) between the iP 
and iNP strains [55].
Consistent with the P and NP findings, the deletion of Snca in mice significantly decreases 
alcohol consumption relative to wild-type [10]. Furthermore, compared to alcohol-naïve 
controls, monkeys that chronically self-administered alcohol for 18 months exhibit a 3-fold 
increase in Snca mRNA measured in peripheral blood [56]. Likewise, elevated Snca 
(mRNA, protein) levels were detected in alcoholics [57], and Snca DNA sequence variants 
have been linked to craving for alcohol in humans [16, 17]. In addition to alcohol-related 
phenotypes, elevated SNCA levels in midbrain dopaminergic neurons were detected in both 
cocaine abusers and mice in withdrawal following morphine treatment [58, 59]. Therefore, 
due to its effects on dopaminergic neurotransmission, Snca is a candidate gene of 
considerable interest to alcohol-seeking behavior.
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Corticotrophin-Releasing Factor Receptor 2 (Crhr2)
Hypothalamic-pituitary-adrenal (HPA) axis regulation is an important component of stress 
response and has been implicated in both anxiety as well as alcohol-seeking behavior (see 
following review [60]). Studies suggest that CRHR2 functions in the hypothalamus and 
amygdala as an inhibitory or modulatory receptor to dampen HPA activation; thereby, 
CRHR2 is thought to promote adaptation and recovery from environmental stressors [61]. 
An inverse relationship has been detected between Crhr2 expression and alcohol-seeking 
behavior. The iP relative to iNP rats exhibit decreased Crhr2 mRNA expression in various 
regions of the limbic system [37]. Crhr2’s DNA sequence exhibits two polymorphisms 
(3′UTR, coding) between iP and iNP rats that could potentially influence gene expression or 
CRHR2 binding affinity [37]. These polymorphisms are currently being tested for their 
functional significance.
In addition to the P and NP findings, the administration of the CRHR2 selective agonist 
urocortin 3 (UCN 3) reverses the increases in ethanol self-administration during the early 
stages of ethanol withdrawal [12], and the infusion of UCN 3 into the central amygdala 
(CeA) decreases ethanol self-administration in ethanol dependent Wistar rats [13]. This 
reduction in alcohol self-administration seen during CRHR2 activation within the CeA may 
be related to a decrease in anxiety-like behavior [13]. Therefore, due to its involvement in 
the modulation of anxiety as well as stress responsivity (HPA-axis regulation), Crhr2 
represents an interesting target for alcohol-seeking behavior.
CONCLUSION
The identification of the genetic factors that influence addictive behavior can provide 
important targets for both basic and clinical research. In the P and NP model, QTL mapping 
(QTL analysis, fine-mapping) and molecular-based research were implemented as 
complementary approaches to identify and prioritize promising genetic targets for alcohol-
seeking behavior. In an attempt to validate the resulting genes of interest, hypothesis-driven 
research has been used to independently corroborate results. With the recent advancements 
in molecular biology and bioinformatics, QTL mapping and molecular-based strategies 
applied to selectively bred and inbred strains provide a multifaceted approach to target high-
priority genes that contribute to alcohol dependence.
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ABBREVIATIONS
P Alcohol-preferring
NP Alcohol-nonpreferring
iP Inbred P
iNP Inbred NP
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QTL Quantitative trait locus
cM centiMorgan
LOD Logarithm of the odds
ISCS Interval specific congenic strain
TOGA Total gene expression analysis
qRT-PCR Real-time quantitative reverse transcription PCR
3′UTR 3′-Untranslated region
luc Luciferase
DA Dopamine
HPA Hypothalamic-pituitary-adrenal
CeA Central amygdala
Npy Neuropeptide Y
Snca Alpha-synuclein
Crhr2 Corticotrophin-releasing factor receptor 2
Ucn 3 Urocortin 3
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Key Learning Objectives
• The overall objective of this research is to identify genes that influence alcohol-
drinking behavior.
• To target high-priority genes, QTL mapping and molecular techniques were 
applied to selectively bred and inbred strains developed from Wistar rats.
• Following their initial identification, these genetic targets can be validated using 
several independent measures.
• These complementary strategies represent a step-wise approach that can be used 
to identify and confirm candidate genes for alcohol-drinking behavior.
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Future Research Questions
• Future studies will test how alcohol affects the candidate gene expression in the 
iP and iNP strains.
• The chromosome 4 QTL region will be fine-mapped to 2 cM using interval 
specific congenic strains (ISCSs).
• Microarray analysis will be used to determine how the transfer of the 
chromosome 4 QTL interval affects mRNA expression by comparing the iP and 
congenic P.NP strains.
Spence et al. Page 16
Curr Drug Abuse Rev. Author manuscript; available in PMC 2015 June 04.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 1. 
An illustration of a stepwise approach to target and attempt to validate candidate genes 
associated with a heritable trait. Following selective breeding and inbreeding, QTL mapping 
strategies were applied to the inbred P and NP strains in order to identify chromosomal 
regions that are correlated with alcohol consumption, the quantitative trait of interest. To 
target specific genes of interest, molecular-based strategies were implemented to screen for 
genetic targets that map to the chromosome 4 QTL region and display differences in gene 
expression and DNA sequence polymorphism. These complementary molecular-base 
strategies were utilized to identify and prioritize genetic targets for hypothesis-driven 
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research. In an attempt to validate and further characterize the genes of interest, genetic 
(e.g., knockout, transgenic), pharmacological interventions (e.g., targeting associated 
receptors, enzymes and or transporters), and human association studies can provide 
corroborative evidence, ultimately defining the relevance of each candidate gene to alcohol-
seeking behavior.
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Fig. 2. 
A QTL for alcohol consumption identified on rat chromosome 4 in iP and iNP rats. Boxes 
and arrows illustrate the basic methodologies that were incorporated to conduct QTL 
analysis in the P and NP strains. Using bidirectional selective breeding, the alcohol-
preferring (P) and –nonpreferring (NP) rat strains were developed from a closed colony of 
Wistar rats (top box). The inbred P (iP) and NP (iNP) strains were later developed from the 
P and NP strains using brother-sister mating for over 20 generations. To perform QTL 
analysis, the iP and iNP strains were crossed to generate iP x iNP F1 animals, and these F1 
animals were subsequently bred to generate the iP x iNP F2 population. In the F2 animals, 
free choice alcohol consumption (g/kg/day) and alcohol preference (v/v) were measured, 
and polymorphic microsatellite markers were genotyped. A genome screen was then 
performed to identify chromosomal regions that segregate with the alcohol consumption 
phenotype. Linkage analysis detected a highly significant QTL (lod score = 9.2) for alcohol 
consumption on rat chromosome 4. Thus far, three candidate genes have been identified that 
underlie the peak of this linkage signal including neuropeptide Y (Npy), α-synuclein (Snca), 
corticotrophin releasing factor receptor 2 (Crhr2).
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